Nuvation Bio NUVB Stock
Nuvation Bio Price Chart
Nuvation Bio NUVB Financial and Trading Overview
| Nuvation Bio stock price | 1.82 USD |
| Previous Close | 2.63 USD |
| Open | 2.62 USD |
| Bid | 2.54 USD x 1200 |
| Ask | 2.55 USD x 3100 |
| Day's Range | 2.5 - 2.63 USD |
| 52 Week Range | 1.21 - 4.16 USD |
| Volume | 978.93K USD |
| Avg. Volume | 1.73M USD |
| Market Cap | 856.56M USD |
| Beta (5Y Monthly) | 1.359 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.5 USD |
NUVB Valuation Measures
| Enterprise Value | 347.23M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.039683 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 396.19012 |
| Price/Book (mrq) | 1.7023412 |
| Enterprise Value/Revenue | 160.605 |
| Enterprise Value/EBITDA | -2.593 |
Trading Information
Nuvation Bio Stock Price History
| Beta (5Y Monthly) | 1.359 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 4.16 USD |
| 52 Week Low | 1.21 USD |
| 50-Day Moving Average | 2.55 USD |
| 200-Day Moving Average | 2.76 USD |
NUVB Share Statistics
| Avg. Volume (3 month) | 1.73M USD |
| Avg. Daily Volume (10-Days) | 2.6M USD |
| Shares Outstanding | 335.57M |
| Float | 233.83M |
| Short Ratio | 7.28 |
| % Held by Insiders | 26.84% |
| % Held by Institutions | 56.33% |
| Shares Short | 11.32M |
| Short % of Float | 4.71% |
| Short % of Shares Outstanding | 3.35% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | September 30, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -6616.36% |
| Gross Margin | -32.37% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.97% |
| Return on Equity (ttm) | -95.53% |
Income Statement
| Revenue (ttm) | 2.16M USD |
| Revenue Per Share (ttm) | 0.009 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -133927000 USD |
| Net Income Avi to Common (ttm) | -532280992 USD |
| Diluted EPS (ttm) | -2.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 549.13M USD |
| Total Cash Per Share (mrq) | 1.63 USD |
| Total Debt (mrq) | 11.19M USD |
| Total Debt/Equity (mrq) | 2.23 USD |
| Current Ratio (mrq) | 9.57 |
| Book Value Per Share (mrq) | 1.495 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -99140000 USD |
| Levered Free Cash Flow (ttm) | -33288250 USD |
Profile of Nuvation Bio
| Country | United States |
| State | NY |
| City | New York |
| Address | 1500 Broadway |
| ZIP | 10036 |
| Phone | 332 208 6102 |
| Website | https://www.nuvationbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 203 |
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York.
Q&A For Nuvation Bio Stock
What is a current NUVB stock price?
Nuvation Bio NUVB stock price today per share is 1.82 USD.
How to purchase Nuvation Bio stock?
You can buy NUVB shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nuvation Bio?
The stock symbol or ticker of Nuvation Bio is NUVB.
Which industry does the Nuvation Bio company belong to?
The Nuvation Bio industry is Biotechnology.
How many shares does Nuvation Bio have in circulation?
The max supply of Nuvation Bio shares is 364.31M.
What is Nuvation Bio Price to Earnings Ratio (PE Ratio)?
Nuvation Bio PE Ratio is now.
What was Nuvation Bio earnings per share over the trailing 12 months (TTM)?
Nuvation Bio EPS is -2.18 USD over the trailing 12 months.
Which sector does the Nuvation Bio company belong to?
The Nuvation Bio sector is Healthcare.
Nuvation Bio NUVB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE COMPOSITE (DJ) NYA | 19823.48 USD — |
-1.02
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}